Other

Neoplasm by Morphology

Non-malignant13,325 active trials222 approved drugs2,774 evidence items

NCIt: C4741

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (2,105)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 226–250 of 2,105 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.
Hitomi Nakayama, Tomonori Nakazato, Atsushi Takahata et al. · Br J Haematol · Sep 3, 2026 · PMID 42692463 · candidate dictionary pubmed
Machine Learning and Molecular Modeling Reveal HDAC6 as a Key Target of Tanshinone IIA in Multiple Myeloma.
Jian Gao, Jiawen Chu, Pengpeng Li · J Phys Chem B · Sep 3, 2026 · PMID 42691419 · candidate dictionary pubmed
Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.
Marie Christine Wesener, Uta Margareta Demel, Thomas Pabst et al. · Haematologica · Sep 3, 2026 · PMID 42687830 · candidate dictionary pubmed
Exposure-response and dose simulation of belantamab mafodotin in combination with standards of care in patients with relapsed/refractory multiple myeloma.
Sagar Lonial, Paul G Richardson, Geraldine Ferron-Brady et al. · Haematologica · Sep 3, 2026 · PMID 42687822 · candidate dictionary pubmed
Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patients.
Ioannis Ntanasis-Stathopoulos, Panagiota-Efstathia Nikolaou, Charalampos Filippatos et al. · Haematologica · Sep 3, 2026 · PMID 42687818 · candidate dictionary pubmed
Fixed-duration lenalidomide maintenance: considering environmental value in multiple myeloma.
Max Piffoux, Sebastien Taillemite · Haematologica · Sep 3, 2026 · PMID 42687812 · candidate dictionary pubmed

Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experience.

Cirino Botta, Andrea Rizzuto, Maria Speciale et al. · Haematologica · Sep 3, 2026 · PMID 42687806 · candidate dictionary pubmed

Sequenced, Not Stirred: Positioning CAR T and Bispecific Antibody Therapy in Multiple Myeloma.

Rahul Banerjee · Blood Cancer Discov · Sep 3, 2026 · PMID 42593166 · candidate dictionary pubmed

Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

Kylee H Maclachlan, Marios Papadimitriou, Patrick Blaney et al. · Blood Cancer Discov · Sep 3, 2026 · PMID 42284538 · candidate dictionary pubmed

Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

Maximilian Merz, Tomas Jelinek, Thomas Pabst et al. · Blood Cancer Discov · Sep 3, 2026 · PMID 42284467 · candidate dictionary pubmed

A novel triple-knockout allogeneic BCMA CAR T-cell therapy (CT0590) for multiple myeloma: preclinical and phase 1 study.

Song Jin, Zhaohui Liao, Shuang Yan et al. · Blood · Sep 3, 2026 · PMID 42275247 · candidate dictionary pubmed

Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma.

Susan Bal, Myo Htut, Omar Nadeem et al. · Blood · Sep 3, 2026 · PMID 42233419 · candidate dictionary pubmed

BRAF V600E-mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemia.

Jason Love, Tanvi Verma, Phil Palmer et al. · Am J Clin Pathol · Sep 3, 2026 · PMID 42692535 · candidate dictionary pubmed

Neem leaf glycoprotein mediated immunomodulation and epigenetic regulation in Acute Myeloid Leukemia.

Roshni Bibi, Shreyoshi Das, Subham Swopnil Deo et al. · Mol Biol Rep · Sep 3, 2026 · PMID 42690245 · candidate dictionary pubmed

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

Amir T Fathi, Alexander E Perl, Geoffrey G Fell et al. · N Engl J Med · Sep 3, 2026 · PMID 42685316 · candidate dictionary pubmed

CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.

Evey Y F Zheng, Chung-Hsi Wang, Toshiki Ochi et al. · Blood Cancer Discov · Sep 3, 2026 · PMID 42599152 · candidate dictionary pubmed

LY3410738, a Covalent Inhibitor of Mutant IDH1/2, Is Effective in Acute Myeloid Leukemia Preclinical Models.

Nathan A Brooks, Anna Skwarska, Vivian Salama et al. · Blood Cancer Discov · Sep 3, 2026 · PMID 42490065 · candidate dictionary pubmed

Outcomes in clinical stage IB cutaneous melanoma managed with only wide local excision.

Brandon Charles Toliver, Keely Kringlen, Hisakazu Hoshi · Surgery · Sep 3, 2026 · PMID 42786088 · candidate dictionary pubmed

Correlations between autograft cellular components and post-transplant outcome in patients with systemic non-Hodgkin lymphoma mobilized with on-demand plerixafor: A prospective multicenter GOA study.

Anu Partanen, Antti Turunen, Outi Kuittinen et al. · Transfus Apher Sci · Sep 2, 2026 · PMID 42700534 · candidate dictionary pubmed

[Acute myeloid leukemia in "fit" patients : updates on diagnosis and treatment].

Mariangela Costanza, Natacha Dewarrat, Gerasimos Tsilimidos et al. · Rev Med Suisse · Sep 2, 2026 · PMID 42687729 · candidate dictionary pubmed

Pilot study on RECAF (Receptor for Alpha-Fetoprotein) expression in pediatric acute leukemia: insights from flow cytometry analysis.

Soha Raouf Youssef, Mohamed Hany Mohammady, Shams ElDoha Galal ElDin Zaiema · J Egypt Natl Canc Inst · Sep 2, 2026 · PMID 42684636 · candidate dictionary pubmed

Azidothymidine potentiates the immunomodulatory function of interferon-α in adult T cell leukemia/lymphoma.

Xiaoyi Yuan, Dian Zhu, Yi Liang et al. · Mol Ther · Sep 2, 2026 · PMID 42281209 · candidate dictionary pubmed

Damage-Associated Molecular Patterns in Mesothelioma: Drivers of Inflammation and Therapeutic Targets.

Annamaria Molinario, Francesca Caprioglio, Angela A Rilievo et al. · Int J Mol Sci · Sep 2, 2026 · PMID 42737756 · candidate dictionary pubmed

Correction to "Integrating Polygenic and Methylation Risk Scores for Pleural Mesothelioma Risk Stratification".

· Int J Cancer · Sep 1, 2026 · PMID 42233546 · candidate dictionary pubmed

Dramatic Morphometabolic Response to Bevacizumab-Based Chemotherapy After Immunotherapy Failure in Malignant Pleural Mesothelioma on FDG PET.

Kevser Oksuzoglu, Lutfu Perktas, Hasan Onner et al. · Clin Nucl Med · Sep 1, 2026 · PMID 42080609 · candidate dictionary pubmed